BiotechTube
Home/Terns Pharmaceuticals/Christopher Jones
CJ

Christopher Jones

VP, Discovery Research

Terns Pharmaceuticals

Therapeutic Areas

OncologyMetabolic Diseases

Terns Pharmaceuticals Pipeline

DrugIndicationPhase
TERN-701Chronic Myeloid Leukemia (CML)Phase 3
Metabolic / Obesity ProgramsUndisclosed Metabolic Disease / ObesityPreclinical / Early Clinical
Oncology ProgramsUndisclosed Oncology IndicationsPreclinical / Early Clinical

Leadership Team at Terns Pharmaceuticals

AB
Amy Burroughs
Chief Executive Officer
AG
Andrew Gengos
Chief Financial Officer and Head of Corporate Development
SH
Scott Harris
Chief Development and Operations Officer
MS
Melita Sun Jung
Chief Business Officer
EK
Emil Kuriakose
Chief Medical Officer
CM
Caryn McDowell
Chief Legal Officer
RA
Robin Andrulevich
Chief People Officer
JJ
Jeff Jasper
SVP, Senior Distinguished Research Fellow
JK
James Kanter
SVP, CMC
YQ
Yasameen Qazen
SVP, Regulatory Affairs and Quality Assurance
View full Terns Pharmaceuticals profile